TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis

肾小球肾炎中白细胞募集的 TNFR2 调节

基本信息

  • 批准号:
    9456733
  • 负责人:
  • 金额:
    $ 43.01万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Leukocyte accumulation is a hallmark of inflammatory renal diseases. TNF, a potent cytokine that regulates leukocyte trafficking is essential for the development of glomerulonephritis in animal models. Many of the pro- inflammatory responses of TNF in vivo can be attributed to its effects on the vascular endothelium and leukocyte influx. TNF relays its biological activities by two distinct receptors, TNFR1 and TNFR2 with most of TNF's effects on the endothelium being attributed to TNFR1. The contribution of TNFR2 is likely underestimated as it has a higher affinity for the membrane bound versus the soluble form of the cytokine and it is not constitutively expressed in all endothelial cell cultures. Our recently published data demonstrate that engagement of TNFR2 in cultured endothelial cells triggers Interferon regulatory factor-1 (IRF-1) induced IFNß synthesis, and subsequent autocrine signaling via the IFNα/ß receptor, to generate mononuclear cell chemoattractants. In vivo, acute renal inflammation induced by intravenously administered recombinant TNF results in neutrophil and monocyte recruitment in the kidney that requires TNFR1, while the TNFR2-IRF-1- IFNß autocrine loop is essential only for monocyte/macrophage accumulation. In a chronic model of anti- glomerular basement membrane nephritis, renal TNFR2 and IRF-1 but not TNFR1 are essential for sustained macrophage accumulation. Thus, our data identify a previously unrecognized TNFR2-IRF-1-IFNß-IFNα/ß receptor-signaling pathway in endothelial cells that promotes monocyte recruitment. These findings may have relevance in humans as TNFR2, absent in normal human kidney, is robustly induced on the glomerular endothelium of patients with anti-GBM nephritis. Our results raise two important questions: How does TNFR2 induce IRF-1, and what steps of leukocyte recruitment in the kidney are regulated by TNFR2 and its associated IFNß autocrine loop? These questions will be addressed in three specific aims: I) Delineate TNFR2 proximal intracellular signals that link TNFR2 to IRF-1 and IFNß production; II) Conduct intravital microscopy in the intact kidney to elucidate pathways of renal leukocyte recruitment triggered by TNF; and III) Elucidate the molecular requirements for renal TNFR2 and components of the IFNß autocrine loop in the dynamics of monocyte recruitment. For Aims II and III, we have developed a multiphoton intravital microscopy approach for time-lapse imaging of leukocyte behavior in the glomerular and peritubular capillaries of mice. Determining how TNF-induced amplification of IFNß expression and IFNß-signaling locally in the endothelium leads to monocyte accumulation in the kidney could result in important new insights into the pathogenesis of glomerulonephritis and lead to new therapeutic targets.
描述(由申请方提供):白细胞蓄积是炎症性肾病的标志。TNF是一种调节白细胞运输的强效细胞因子,在动物模型中对肾小球肾炎的发展至关重要。TNF在体内的许多促炎反应可归因于其对血管内皮和白细胞内流的作用。TNF通过两种不同的受体TNFR 1和TNFR 2传递其生物活性,其中TNF对内皮的大部分作用归因于TNFR 1。TNFR 2的贡献可能被低估,因为它对膜结合的细胞因子的亲和力高于可溶性形式的细胞因子,并且它不是在所有内皮细胞培养物中组成型表达的。我们最近发表的数据表明,TNFR 2在培养的内皮细胞中的参与触发干扰素调节因子-1(IRF-1)诱导的IFN α合成,以及随后通过IFNα/IFN α受体的自分泌信号传导,以产生单核细胞化学引诱物。在体内,由静脉内施用的重组TNF诱导的急性肾脏炎症导致需要TNFR 1的肾脏中的中性粒细胞和单核细胞募集,而TNFR 2-IRF-1-IFN β自分泌环仅对于单核细胞/巨噬细胞积累是必需的。在抗肾小球基底膜肾炎的慢性模型中,肾TNFR 2和IRF-1而不是TNFR 1对于持续的巨噬细胞积聚是必需的。因此,我们的数据确定了一个以前未被识别的TNFR 2-IRF-1-IFN α-IFNα/IFN α受体信号通路,在内皮细胞中促进单核细胞募集。这些发现在人类中可能具有相关性,因为在正常人肾脏中不存在的TNFR 2在患有抗GBM肾炎的患者的肾小球内皮上被强烈诱导。我们的研究结果提出了两个重要的问题:TNFR 2如何诱导IRF-1,以及TNFR 2及其相关的IFN-γ自分泌回路调节肾脏中白细胞募集的步骤。这些问题将在三个具体目标中得到解决:I)描绘将TNFR 2与IRF-1和IFN β产生联系起来的TNFR 2近端细胞内信号; II)在完整肾脏中进行活体显微镜检查,以阐明TNF触发的肾脏白细胞募集途径;和III)阐明单核细胞募集动力学中肾脏TNFR 2和IFN β自分泌环组分的分子要求。对于目标II和III,我们已经开发了一种多光子活体显微镜方法,用于小鼠肾小球和管周毛细血管中白细胞行为的延时成像。确定TNF-诱导的IFN-γ表达的扩增和IFN-γ信号传导如何局部地在内皮中导致单核细胞在肾脏中的积累,可能导致对肾小球肾炎发病机制的重要新见解,并导致新的治疗靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tanya N Mayadas其他文献

Tanya N Mayadas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tanya N Mayadas', 18)}}的其他基金

Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
  • 批准号:
    10326852
  • 财政年份:
    2020
  • 资助金额:
    $ 43.01万
  • 项目类别:
Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
  • 批准号:
    10569637
  • 财政年份:
    2020
  • 资助金额:
    $ 43.01万
  • 项目类别:
TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis
肾小球肾炎中白细胞募集的 TNFR2 调节
  • 批准号:
    8821615
  • 财政年份:
    2014
  • 资助金额:
    $ 43.01万
  • 项目类别:
Physiological and Molecular Imaging
生理和分子成像
  • 批准号:
    7753056
  • 财政年份:
    2009
  • 资助金额:
    $ 43.01万
  • 项目类别:
cAMP Control of Endothelial Barrier and T Cell Migration
cAMP 控制内皮屏障和 T 细胞迁移
  • 批准号:
    7753048
  • 财政年份:
    2009
  • 资助金额:
    $ 43.01万
  • 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
  • 批准号:
    7903751
  • 财政年份:
    2009
  • 资助金额:
    $ 43.01万
  • 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
  • 批准号:
    7620123
  • 财政年份:
    2007
  • 资助金额:
    $ 43.01万
  • 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
  • 批准号:
    7322748
  • 财政年份:
    2007
  • 资助金额:
    $ 43.01万
  • 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
  • 批准号:
    8209095
  • 财政年份:
    2003
  • 资助金额:
    $ 43.01万
  • 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
  • 批准号:
    7582061
  • 财政年份:
    2003
  • 资助金额:
    $ 43.01万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.01万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了